Global Infectious Disease Diagnostics Testing Market Overview And Statistics For 2024-2033

The Business Research Company's Infectious Disease Diagnostics Testing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 31, 2024 /EINPresswire.com/ -- The infectious disease diagnostics testing market has experienced robust growth in recent years, expanding from $35.09 billion in 2023 to $38.52 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.

Strong Future Growth Anticipated
The infectious disease diagnostics testing market is projected to continue its strong growth, reaching $58.84 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers.

Explore Comprehensive Insights Into The Global Infectious Disease Diagnostics Testing Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15831&type=smp

Growth Driver Of The Infectious Disease Diagnostics Testing Market
A rise in respiratory infections is expected to propel the growth of the infectious disease diagnostic testing market going forward. Respiratory infections affect the respiratory system, including the nose, throat, airways, and lungs. The increasing respiratory infections are due to viral and bacterial transmission through close contact with infected individuals, poor hygiene practices, crowded living conditions, and seasonal variations in weather patterns. Infectious disease diagnostic testing is essential for diagnosing and treating respiratory infections as it can precisely identify pathogens such as bacteria and viruses in patient samples.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Major Players And Market Trends
Key players in the infectious disease diagnostics testing market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG.
Major companies operating in the infectious disease diagnostic testing market are focusing on developing innovative technologies, such as molecular diagnostics platforms, to sustain their position in the market. Molecular diagnostics platforms are sophisticated systems designed to detect and analyze nucleic acids (DNA or RNA) from biological samples for diagnostic purposes.

Segments:
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Infectious Disease Diagnostics Testing Market Definition
Infectious disease diagnostics testing refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are crucial for diagnosing infectious diseases and guiding appropriate treatment decisions. Infectious disease diagnostics testing plays a vital role in controlling the spread of infectious diseases, guiding treatment decisions, and monitoring outbreaks.

Infectious Disease Diagnostics Testing Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Infectious Disease Diagnostics Testing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on infectious disease diagnostics testing market size, infectious disease diagnostics testing market drivers and trends, infectious disease diagnostics testing market major players, infectious disease diagnostics testing competitors' revenues, infectious disease diagnostics testing market positioning, and infectious disease diagnostics testing market growth across geographies. The infectious disease diagnostics testing market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
PCR And Realtime PCR Testing Global Market Opportunities And Strategies To 2030: COVID-19 Implication And Growth
https://www.thebusinessresearchcompany.com/report/pcr-and-rt-pcr-testing

Mycoplasma Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Non-Animal Alternatives Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Illuminating Hope: The Rise of Oncology Biomarkers in the Fight Against Cancer